Rasmus Sejersten Ripa

Rasmus Sejersten Ripa

Postdoc, Clinical Associate Professor

ORCID: 0000-0003-2035-2321

Publication year:
All
76 - 92 out of 92Page size: 25
  1. 2006

  2. Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy?

    Kastrup, J., Ripa, Rasmus Sejersten, Wang, Y. & Jørgensen, E., Dec 2006, In: European Heart Journal. 27, 23, p. 2748-54 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial

    Sejersten, M., Birnbaum, Y., Ripa, Rasmus Sejersten, Maynard, C., Wagner, G. S., Clemmensen, P. & DANAMI-2 Investigators, D. I., Nov 2006, In: Heart. 92, 11, p. 1577-82 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Epo 'cytokine-doping' of heart disease patients, will it work?

    Jørgensen, E., Bindslev, L., Ripa, Rasmus Sejersten & Kastrup, J., Aug 2006, In: European Heart Journal. 27, 15, p. 1767-8 2 p.

    Research output: Contribution to journal › Journal article › Research

  5. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease

    Ripa, Rasmus Sejersten, Wang, Y., Jørgensen, E., Johnsen, H. E., Hesse, B. & Kastrup, J., Aug 2006, In: European Heart Journal. 27, 15, p. 1785-92 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. In-stent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor Preliminary intracoronary ultrasound results from a double-blind randomized placebo-controlled study of patients treated with percutaneous coronary intervention for ST-elevation myocardial infarction (STEMMI Trial)

    Jørgensen, E., Ripa, Rasmus Sejersten, Helqvist, S., Wang, Y., Johnsen, H. E., Grande, P. & Kastrup, J., 28 Jul 2006, In: International Journal of Cardiology. 111, 1, p. 174-7 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention

    Wang, Y., Johnsen, H. E., Mortensen, S., Bindslev, L., Ripa, Rasmus Sejersten, Haack-Sørensen, M., Jørgensen, E., Fang, W. & Kastrup, J., Jun 2006, In: Heart. 92, 6, p. 768-74 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Usefulness of quantitative baseline ST-segment elevation for predicting outcomes after primary coronary angioplasty or fibrinolysis (results from the DANAMI-2 trial)

    Sejersten, M., Ripa, Rasmus Sejersten, Maynard, C., Wagner, G. S., Andersen, H. R., Grande, P., Mortensen, L. S. & Clemmensen, P., 1 Mar 2006, In: American Journal of Cardiology. 97, 5, p. 611-6 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial

    Ripa, Rasmus Sejersten, Jørgensen, E., Wang, Y., Thune, J. J., Nilsson, J. C., Søndergaard, Lars, Johnsen, H. E., Køber, Lars Valeur, Grande, P. & Kastrup, J., 2006, In: Circulation. 113, 16, p. 1983-92 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. 2005

  11. Consideration of the total ST-segment deviation on the initial electrocardiogram for predicting final acute posterior myocardial infarct size in patients with maximum ST-segment deviation as depression in leads V1 through V3. A FRISC II substudy

    Ripa, Rasmus Sejersten, Holmvang, L., Maynard, C., Sejersten, M., Clemmensen, P., Grande, P., Lindahl, B., Lagerqvist, B., Wallentin, L. & Wagner, G. S., Jul 2005, In: Journal of Electrocardiology. 38, 3, p. 180-6 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease

    Wang, Y., Tägil, K., Ripa, Rasmus Sejersten, Nilsson, J. C., Carstensen, S., Jørgensen, E., Søndergaard, L., Hesse, B., Johnsen, H. E. & Kastrup, J., 28 Apr 2005, In: International Journal of Cardiology. 100, 3, p. 477-83 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Comparison between human and automated electrocardiographic waveform measurements for calculating the Anderson-Wilkins acuteness score in patients with acute myocardial infarction

    Ripa, Rasmus Sejersten, Persson, E., Hedén, B., Maynard, C., Christian, T. F., Hammill, S., Pahlm, O. & Wagner, G. S., Apr 2005, In: Journal of Electrocardiology. 38, 2, p. 96-9 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer

    Ripa, Rasmus Sejersten, Katballe, N., Wikman, F., Jäger, A. C., Bernstein, I., Orntoft, T., Schwartz, M., Nielsen, F. C. & Bisgaard, M. L., 15 Feb 2005, In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 570, 1, p. 89-96 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Safety of bone-marrow stem cell mobilisation induced by granulocyte-colony stimulating factor: Clinical 30 days blinded results from the stem cells in myocardial infarction (STEMMI) trial

    Ripa, Rasmus Sejersten, Wang, Y., Jørgensen, E., Johnsen, H. E., Grande, P. & Kastrup, J., 2005, In: HeartDrug. 5, p. 177-82 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. 2004

  17. Mutation analysis of the adenomatous polyposis coli (APC) gene in Danish patients with familial adenomatous polyposis (FAP)

    Bisgaard, M. L., Ripa, Rasmus Sejersten & Bülow, S., May 2004, In: Human Mutation. 23, 5, p. 522

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype

    Bisgaard, M. L., Ripa, Rasmus Sejersten, Knudsen, A. L. & Bülow, S., Feb 2004, In: Gut. 53, 2, p. 266-70 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. 2003

  20. A modified Anderson-Wilkins electrocardiographic acuteness score for anterior or inferior myocardial infarction

    Hedén, B., Ripa, Rasmus Sejersten, Persson, E., Song, Q., Maynard, C., Leibrandt, P., Wall, T., Christian, T. F., Hammill, S. C., Bell, S. S., Pahlm, O. & Wagner, G. S., Nov 2003, In: American Heart Journal. 146, 5, p. 797-803 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. 2002

  22. De novo mutations in familial adenomatous polyposis (FAP)

    Ripa, Rasmus Sejersten, Bisgaard, M. L., Bülow, S. & Nielsen, F. C., Oct 2002, In: European Journal of Human Genetics. 10, 10, p. 631-7 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 Next

ID: 45867987